BDBM50207806 31-(dimethylamino)-5,15,25,30-tetraazaheptacyclo[27.2.2.1^{5,12}.1^{18,25}.0^{6,11}.0^{13,17}.0^{19,24}]pentatriaconta-1(31),6(11),7,9,12(35),13(17),18(34),19(24),20,22,29,32-dodecaene-14,16-dione::CHEMBL392167

SMILES CN(C)c1nc2CCCn3cc(C4=C(C(=O)NC4=O)c4cn(CCCc1cc2)c1ccccc41)c1ccccc31

InChI Key InChIKey=RBUVCVIKSPNSSA-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50207806   

TargetGlycogen synthase kinase-3 beta(Human)
Johnson & Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50207806(31-(dimethylamino)-5,15,25,30-tetraazaheptacyclo[2...)
Affinity DataIC50: 37nMAssay Description:Inhibition of human recombinant GSK3-betaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2012
Entry Details Article
PubMed